Tetravalent influenza virus subunit vaccine (Ab&B BIO-TECH)

四价流感病毒亚单位疫苗（江苏中慧元通生物）

Report date: 2024/12/06 11:04:17

Base Information

Drug NameTetravalent influenza virus subunit vaccine (Ab&B BIO-TECH)
Drug Alias Name慧尔康欣
ClassificationVaccines > Biological material > Viral vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, HumanCommon Cold
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2023/05/12
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAb&B Bio-tech Co Ltd JS
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesAb&B Bio-tech Co Ltd JS
Inactive CompaniesYither Biotech (Shanghai) Co Ltd
Active IndicationsInfluenza, HumanCommon Cold
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A